Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Leading Edge Materials' Investor Update and Significant Activities (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cipher Pharmaceuticals Inc
T.CPH
Alternate Symbol(s):
CPHRF
Healthcare
Biotechnology
Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early-to-late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology...
products include Actikerall, Epuris, Vaniqa and Natroba. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. Its Natroba (spinosad) Topical Suspension is indicated for the topical treatment of head lice and scabies infestations in adult and pediatric patients.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:CPH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Next
(6309)
•••
retiredcf
X
Post by
retiredcf
on Mar 12, 2025 4:28pm
Today's Action
Is a pretty good indication that this stock is being played by the Market Makers. Either that, or there is suddenly considerable enthusiasm about the upcoming earnings (after the close on 18 March
...more
(2)
•••
Geisha109
X
Comment by
Geisha109
on Mar 11, 2025 1:57pm
RE:RE:RE:RE:RE:RE:Jason Donnville- BNN comment
What is your thought process for a failure in the US? Because the stock sold off? CPH is an illiquid, relatively unknown stock. Market has sold off, especially small caps. Results coming soon which
...more
(14)
•••
drewmumaw
X
Comment by
drewmumaw
on Mar 07, 2025 1:27pm
RE:RE:RE:RE:RE:Jason Donnville- BNN comment
It's shaping up to be another failed US expansion like 2015. However, we won't know for sure until we see the latest Natroba numbers.
(6309)
•••
retiredcf
X
Post by
retiredcf
on Mar 03, 2025 7:51am
Oversold
Meanwhile, 17 stocks on the negative breakouts list are in oversold territory, as indicated by an RSI reading of 30 or below. They are: Andlauer Healthcare (AND-T), Calian (CGY-T), Canopy Growth (WEED
...more
(377)
•••
1condor
X
Comment by
1condor
on Mar 01, 2025 3:49pm
RE:RE:RE:RE:Jason Donnville- BNN comment
I have been following this stock for the past few months and needless to say its been ugly. Still hear a lot of positives on this stock...yet it continues to fall. Technically the stock is sitting
...more
(6309)
•••
retiredcf
X
Comment by
retiredcf
on Jan 28, 2025 3:03pm
RE:RE:RE:Jason Donnville- BNN comment
He and his family also own all of the top picks personally. GLTA
(1791)
•••
Possibleidiot01
X
Comment by
Possibleidiot01
on Jan 28, 2025 1:36pm
RE:RE:Jason Donnville- BNN comment
Cipher Pharmaceuticals (CPH TSX) Cipher Pharmaceuticals recently went through a series of changes and now has a revamped management team which is led by a CEO who has returned and owns more than 40
...more
(6309)
•••
retiredcf
X
Comment by
retiredcf
on Jan 28, 2025 1:04pm
RE:Jason Donnville- BNN comment
It was Jesse Gamble's final top pick on today's show. For those who are curious, the others were ZDC and E. GLTA
(1791)
•••
Possibleidiot01
X
Post by
Possibleidiot01
on Jan 06, 2025 8:51pm
Jason Donnville- BNN comment
Cipher Pharmeuticals(CPH-T) 06/01/2025 It could become the next Paladin. It has great management and ownership along with a good outlook. It made a big acquisition in the U.S. and if
...more
(194)
•••
Daudau11
X
Comment by
Daudau11
on Dec 10, 2024 9:53pm
RE:MOB-015 N.A. phase 3 study - No N.A. launch
The news from Moberg was release this morning so I think that is why CPH was down today with higher than average volume. CPH might still go down too since after close they now release the news
...more
(0)
•••
Nordlav
X
Post by
Nordlav
on Dec 10, 2024 6:48pm
MOB-015 N.A. phase 3 study - No N.A. launch
Moberg/Bayer abondoning N.A. launch, Moberg will focus on E.U. Looks like Cipher won't have MOB-015 in their quiver anymore, they will communicate a decision in due course. Probably
...more
(194)
•••
Daudau11
X
Comment by
Daudau11
on Nov 12, 2024 5:01pm
RE:RE:Stifel
Tbh, I don't see any stocks I own doing well lately. The only things that are going up nowadays are, Tech/AI and Crypto. Thats like it. Seems like the the market believes
...more
(14)
•••
drewmumaw
X
Comment by
drewmumaw
on Nov 12, 2024 4:05pm
RE:Stifel
I had some time to scan the MD&A today. Let me know if I'm missing anything major, but my key takeaways were: Natroba strongly boosted product revenue. It only has 22% of the US market
...more
(6309)
•••
retiredcf
X
Post by
retiredcf
on Nov 12, 2024 6:52am
Stifel
Cipher Pharmaceuticals Target Lowered by Stifel Nicolaus C$19.00 C$17.00
(57)
•••
mjh9413
X
Post by
mjh9413
on Nov 08, 2024 1:28am
interesting change in costs of operations
eom
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Have you held units of a TD mutual fund through a discount broker? Learn more.
ReGen III: Pioneering a Cleaner Lubricants Future with Patented Re-Refining